Terms: = Endocrine gland cancer AND HEY1, CHF-2, 23462, ENSG00000164683, HESR1, CHF2, HESR-1, MGC1274, HRT-1, OAF1, HERP2
23 results:
1. Olaparib not cost-effective as maintenance therapy for platinum-sensitive, BRCA1/2 germline-mutated metastatic pancreatic cancer.
Mehra T; Lupatsch JE; Kössler T; Dedes K; Siebenhüner AR; von Moos R; Wicki A; Schwenkglenks ME
PLoS One; 2024; 19(4):e0301271. PubMed ID: 38573891
[TBL] [Abstract] [Full Text] [Related]
2.
Chen B; Jiang K; Wang H; Miao L; Lin X; Chen Q; Jing L; Lu X
Front Biosci (Landmark Ed); 2023 Sep; 28(9):220. PubMed ID: 37796700
[TBL] [Abstract] [Full Text] [Related]
3. Histone methyltransferase SETD1A interacts with notch and promotes notch transactivation to augment ovarian cancer development.
Chai H; Pan C; Zhang M; Huo H; Shan H; Wu J
BMC Cancer; 2023 Jan; 23(1):96. PubMed ID: 36707804
[TBL] [Abstract] [Full Text] [Related]
4. CASK regulates Notch pathway and functions as a tumor promoter in pancreatic cancer.
Qu J; Zhou Y; Li Y; Yu J; Wang W
Arch Biochem Biophys; 2021 Apr; 701():108789. PubMed ID: 33548214
[TBL] [Abstract] [Full Text] [Related]
5. BRAF
Traversi F; Stooss A; Dettmer MS; Charles RP
Thyroid; 2021 May; 31(5):787-799. PubMed ID: 33012268
[No Abstract] [Full Text] [Related]
6. Convergence of Wnt and Notch signaling controls ovarian cancer cell survival.
Bocchicchio S; Tesone M; Irusta G
J Cell Physiol; 2019 Dec; 234(12):22130-22143. PubMed ID: 31087357
[TBL] [Abstract] [Full Text] [Related]
7. Histone deacetylase 11 suppresses p53 expression in pituitary tumor cells.
Wang W; Fu L; Li S; Xu Z; Li X
Cell Biol Int; 2017 Dec; 41(12):1290-1295. PubMed ID: 28782861
[TBL] [Abstract] [Full Text] [Related]
8. Gamma secretase inhibitor impairs epithelial-to-mesenchymal transition induced by TGF-β in ovarian tumor cell lines.
Pazos MC; Abramovich D; Bechis A; Accialini P; Parborell F; Tesone M; Irusta G
Mol Cell Endocrinol; 2017 Jan; 440():125-137. PubMed ID: 27908834
[TBL] [Abstract] [Full Text] [Related]
9. The Epstein-Barr virus EBNA2 protein induces a subset of NOTCH target genes in thyroid cancer cell lines but fails to suppress proliferation.
Golden S; Yu XM; Odorico S; Jain V; Marin A; Ma S; Kenney S; Chen H
Surgery; 2017 Jan; 161(1):195-201. PubMed ID: 27847111
[TBL] [Abstract] [Full Text] [Related]
10. Expression of activated Notch1 and hey1 in papillary thyroid carcinoma.
Jung CW; Kong JS; Seol H; Park S; Koh JS; Lee SS; Kim MJ; Choi IJ; Myung JK
Histopathology; 2017 Jan; 70(2):301-308. PubMed ID: 27542980
[TBL] [Abstract] [Full Text] [Related]
11. Galectin-3 supports stemness in ovarian cancer stem cells by activation of the Notch1 intracellular domain.
Kang HG; Kim DH; Kim SJ; Cho Y; Jung J; Jang W; Chun KH
Oncotarget; 2016 Oct; 7(42):68229-68241. PubMed ID: 27626163
[TBL] [Abstract] [Full Text] [Related]
12. Pancreatic involvement by mesenchymal chondrosarcoma harboring the hey1-NCOA2 gene fusion.
Cohen JN; Solomon DA; Horvai AE; Kakar S
Hum Pathol; 2016 Dec; 58():35-40. PubMed ID: 27544802
[TBL] [Abstract] [Full Text] [Related]
13. [Expression of Jagged1 mRNA in human epithelial ovarian carcinoma tissues and effect of RNA interference of Jagged1 on growth of xenograft in nude mice].
Liu GY; Gao ZH; Li L; Song TT; Sheng XG
Zhonghua Fu Chan Ke Za Zhi; 2016 Jun; 51(6):448-53. PubMed ID: 27356481
[TBL] [Abstract] [Full Text] [Related]
14. Withaferin a alone and in combination with cisplatin suppresses growth and metastasis of ovarian cancer by targeting putative cancer stem cells.
Kakar SS; Ratajczak MZ; Powell KS; Moghadamfalahi M; Miller DM; Batra SK; Singh SK
PLoS One; 2014; 9(9):e107596. PubMed ID: 25264898
[TBL] [Abstract] [Full Text] [Related]
15. Thiocoraline alters neuroendocrine phenotype and activates the Notch pathway in MTC-TT cell line.
Tesfazghi S; Eide J; Dammalapati A; Korlesky C; Wyche TP; Bugni TS; Chen H; Jaskula-Sztul R
Cancer Med; 2013 Oct; 2(5):734-43. PubMed ID: 24403239
[TBL] [Abstract] [Full Text] [Related]
16. DCLK1 marks a morphologically distinct subpopulation of cells with stem cell properties in preinvasive pancreatic cancer.
Bailey JM; Alsina J; Rasheed ZA; McAllister FM; Fu YY; Plentz R; Zhang H; Pasricha PJ; Bardeesy N; Matsui W; Maitra A; Leach SD
Gastroenterology; 2014 Jan; 146(1):245-56. PubMed ID: 24096005
[TBL] [Abstract] [Full Text] [Related]
17. Ellagic acid inhibits human pancreatic cancer growth in Balb c nude mice.
Zhao M; Tang SN; Marsh JL; Shankar S; Srivastava RK
Cancer Lett; 2013 Sep; 337(2):210-7. PubMed ID: 23684930
[TBL] [Abstract] [Full Text] [Related]
18. Notch signaling pathway targeted therapy suppresses tumor progression and metastatic spread in pancreatic cancer.
Yabuuchi S; Pai SG; Campbell NR; de Wilde RF; De Oliveira E; Korangath P; Streppel MM; Rasheed ZA; Hidalgo M; Maitra A; Rajeshkumar NV
Cancer Lett; 2013 Jul; 335(1):41-51. PubMed ID: 23402814
[TBL] [Abstract] [Full Text] [Related]
19. Notch3 and HEY-1 as prognostic biomarkers in pancreatic adenocarcinoma.
Mann CD; Bastianpillai C; Neal CP; Masood MM; Jones DJ; Teichert F; Singh R; Karpova E; Berry DP; Manson MM
PLoS One; 2012; 7(12):e51119. PubMed ID: 23226563
[TBL] [Abstract] [Full Text] [Related]
20. Heterogeneity in signaling pathways of gastroenteropancreatic neuroendocrine tumors: a critical look at notch signaling pathway.
Wang H; Chen Y; Fernandez-Del Castillo C; Yilmaz O; Deshpande V
Mod Pathol; 2013 Jan; 26(1):139-47. PubMed ID: 22918166
[TBL] [Abstract] [Full Text] [Related]
[Next]
